BRISTOL MYERS SQUIBB CO — Investor Relations & Filings
Filings indexed
3,432
across all filing types
Latest filing
2026-04-30
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
BMY
Bristol Myers Squibb is a global biopharmaceutical company engaged in the discovery, development, licensing, manufacturing, and commercialization of innovative medicines. The company focuses on addressing serious diseases with significant unmet medical needs, with core therapeutic areas in oncology, immunology, and cardiovascular disease. Its operations encompass the entire product lifecycle, from scientific research and clinical trials to the global distribution and sale of its biopharmaceutical products. The company's mission is to help patients prevail over serious diseases through scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-04-30 | English | |
| 8-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - BRISTOL MYERS SQUIBB CO (0000014272) (Subject) | 2026-03-26 | English | |
| ARS - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-03-25 | English | |
| DEF 14A - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-03-25 | English | |
| 4 - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39129378 | 10-Q - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-04-30 | English | ||
| 39069674 | 8-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-04-30 | English | ||
| 33052309 | SCHEDULE 13G/A - BRISTOL MYERS SQUIBB CO (0000014272) (Subject) | 2026-03-26 | English | ||
| 33043067 | ARS - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-03-25 | English | ||
| 33042799 | DEF 14A - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-03-25 | English | ||
| 32874910 | 4 - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) | 2026-03-03 | English | ||
| 19817867 | 10-K Filing | 2026-02-11 | English | ||
| 15474989 | 8-K Filing | 2026-02-05 | English | ||
| 15475090 | 4 Filing | 2026-02-03 | English | ||
| 15475061 | 4 Filing | 2026-02-03 | English | ||
| 15475046 | 4 Filing | 2026-02-03 | English | ||
| 15475042 | 4 Filing | 2026-02-03 | English | ||
| 15475038 | 4 Filing | 2026-02-03 | English | ||
| 15475009 | 4 Filing | 2026-02-03 | English | ||
| 15475003 | 4 Filing | 2026-02-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BRISTOL MYERS SQUIBB CO via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29889/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29889 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29889 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29889 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29889}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BRISTOL MYERS SQUIBB CO (id: 29889)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.